{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:10:35Z","timestamp":1793502635008,"version":"4.5.0"},"reference-count":169,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key R&amp;D Program of China","award":["2018YFA0703100"],"award-info":[{"award-number":["2018YFA0703100"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072493"],"award-info":[{"award-number":["82072493"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770882"],"award-info":[{"award-number":["81770882"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570532"],"award-info":[{"award-number":["81570532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971329"],"award-info":[{"award-number":["81971329"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Science and Technology Research Funding","award":["KQJSCX20180330170052049"],"award-info":[{"award-number":["KQJSCX20180330170052049"]}]},{"name":"Shenzhen Science and Technology Research Funding","award":["20170502171625936"],"award-info":[{"award-number":["20170502171625936"]}]},{"name":"Guangdong Special Support Program","award":["2017TQ04R394"],"award-info":[{"award-number":["2017TQ04R394"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver dysfunction and is characterized by exaggerated lipid accumulation, inflammation and even fibrosis. It has been shown that NAFLD increases the risk of other chronic diseases, particularly chronic kidney disease (CKD). Lipid in excess could lead to liver and kidney lesions and even end-stage disease through diverse pathways. Dysregulation of lipid uptake, oxidation or de novo lipogenesis contributes to the toxic effects of ectopic lipids which promotes the development and progression of NAFLD and CKD via triggering oxidative stress, apoptosis, pro-inflammatory and profibrotic responses. Importantly, dyslipidemia and release of pro-inflammatory cytokines caused by NAFLD (specifically, nonalcoholic steatohepatitis) are considered to play important roles in the pathological progression of CKD. Growing evidence of similarities between the pathogenic mechanisms of NAFLD and those of CKD has attracted attention and urged researchers to discover their common therapeutic targets. Here, we summarize the current understanding of molecular aberrations underlying the lipid metabolism of NAFLD and CKD and clinical evidence that suggests the relevance of these pathways in humans. This review also highlights the orchestrated inter-organ cross-talk in lipid disorders, as well as therapeutic options and opportunities to counteract NAFLD and CKD.<\/jats:p>","DOI":"10.3390\/biomedicines9101405","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T10:36:57Z","timestamp":1633516617000},"page":"1405","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Lipid Disorders in NAFLD and Chronic Kidney Disease"],"prefix":"10.3390","volume":"9","author":[{"given":"Meng","family":"Yang","sequence":"first","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Institute of Biochemistry and Molecular Biology, Institute of Aging Research, Guangdong Medical University, Dongguan 523808, China"},{"name":"Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-An","family":"Geng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9033-9099","authenticated-orcid":false,"given":"Xinguang","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Institute of Biochemistry and Molecular Biology, Institute of Aging Research, Guangdong Medical University, Dongguan 523808, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3851-8553","authenticated-orcid":false,"given":"Min","family":"Guan","sequence":"additional","affiliation":[{"name":"Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The Global Epidemiology of Nafld and Nash in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological Features of Nafld from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular Mechanisms of Hepatic Lipid Accumulation in Non-Alcoholic Fatty Liver Disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic Complications of Nonalcoholic Fatty Liver Disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrneph.2016.163","article-title":"The Global Burden of Chronic Kidney Disease: Estimates, Variability and Pitfalls","volume":"13","author":"Glassock","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic Kidney Disease: Global Dimension and Perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"F375","DOI":"10.1152\/ajprenal.00266.2016","article-title":"A Perspective on Chronic Kidney Disease Progression","volume":"312","author":"Zhong","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/ndt\/gfr547","article-title":"Measuring the Population Burden of Chronic Kidney Disease: A Systematic Literature Review of the Estimated Prevalence of Impaired Kidney Function","volume":"27","author":"McCullough","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molmet.2018.07.006","article-title":"Intracellular Lipids Are an Independent Cause of Liver Injury and Chronic Kidney Disease in Non Alcoholic Fatty Liver Disease-Like Context","volume":"16","author":"Monteillet","year":"2018","journal-title":"Mol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s11255-014-0796-9","article-title":"Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease in Population with Prediabetes or Diabetes","volume":"46","author":"Li","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of Non-Alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-Analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"Nafld: A Multisystem Disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7150\/ijbs.30121","article-title":"Role of Nutrition in the Pathogenesis and Prevention of Non-Alcoholic Fatty Liver Disease: Recent Updates","volume":"15","author":"Ullah","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_15","first-page":"1599","article-title":"Mechanisms and Consequences of Hypertriglyceridemia and Cellular Lipid Accumulation in Chronic Kidney Disease and Metabolic Syndrome","volume":"26","author":"Lee","year":"2011","journal-title":"Histol. Histopathol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Marcuccilli, M., and Chonchol, M. (2016). Nafld and Chronic Kidney Disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040562"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"Nafld as a Driver of Chronic Kidney Disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"104840","DOI":"10.1016\/j.phrs.2020.104840","article-title":"18beta-Glycyrrhetinic Acid Acts through Hepatocyte Nuclear Factor 4 Alpha to Modulate Lipid and Carbohydrate Metabolism","volume":"157","author":"Yang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110867","DOI":"10.1016\/j.mce.2020.110867","article-title":"Andrographolide Modulates Hnf4alpha Activity Imparting on Hepatic Metabolism","volume":"513","author":"Zhang","year":"2020","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yang, M., Ma, F., and Guan, M. (2021). Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Metabolites, 11.","DOI":"10.3390\/metabo11050320"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","article-title":"Renal Lipid Metabolism and Lipotoxicity","volume":"19","author":"Bobulescu","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding Lipotoxicity in Nafld Pathogenesis: Is Cd36 a Key Driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOL.0b013e32833b7782","article-title":"Recent Insights into Fatty Liver, Metabolic Dyslipidaemia and Their Links to Insulin Resistance","volume":"21","author":"Savage","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","article-title":"Cd36 Palmitoylation Disrupts Free Fatty Acid Metabolism and Promotes Tissue Inflammation in Non-Alcoholic Steatohepatitis","volume":"69","author":"Zhao","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E384","DOI":"10.1152\/ajpendo.00226.2010","article-title":"Fatp2 Is a Hepatic Fatty Acid Transporter and Peroxisomal Very Long-Chain Acyl-Coa Synthetase","volume":"299","author":"Falcon","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"22186","DOI":"10.1074\/jbc.M803510200","article-title":"Silencing of Hepatic Fatty Acid Transporter Protein 5 in Vivo Reverses Diet-Induced Non-Alcoholic Fatty Liver Disease and Improves Hyperglycemia","volume":"283","author":"Doege","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.jrn.2017.08.005","article-title":"Fatty Acids in Nephrotic Syndrome and Chronic Kidney Disease","volume":"28","author":"Turolo","year":"2018","journal-title":"J. Ren. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1681\/ASN.2017030314","article-title":"Kidney Proximal Tubule Lipoapoptosis Is Regulated by Fatty Acid Transporter-2 (Fatp2)","volume":"29","author":"Khan","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41419-020-03199-x","article-title":"Involvement of Fatp2-Mediated Tubular Lipid Metabolic Reprogramming in Renal Fibrogenesis","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrneph.2017.126","article-title":"Cd36 in Chronic Kidney Disease: Novel Insights and Therapeutic Opportunities","volume":"13","author":"Yang","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of Fatty Acids Stored in Liver and Secreted Via Lipoproteins in Patients with Nonalcoholic Fatty Liver Disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cmet.2011.12.017","article-title":"The Scap\/Srebp Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in Animals","volume":"15","author":"Moon","year":"2012","journal-title":"Cell Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/db06-0200","article-title":"Liver-Specific Inhibition of Chrebp Improves Hepatic Steatosis and Insulin Resistance in Ob\/Ob Mice","volume":"55","author":"Dentin","year":"2006","journal-title":"Diabetes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1172\/JCI94585","article-title":"Divergent Effects of Glucose and Fructose on Hepatic Lipogenesis and Insulin Signaling","volume":"127","author":"Softic","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"18919","DOI":"10.1074\/jbc.M110650200","article-title":"Role of Sterol Regulatory Element-Binding Protein 1 in Regulation of Renal Lipid Metabolism and Glomerulosclerosis in Diabetes Mellitus","volume":"277","author":"Sun","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.2337\/db05-0603","article-title":"Regulation of Renal Fatty Acid and Cholesterol Metabolism, Inflammation, and Fibrosis in Akita and Ove26 Mice with Type 1 Diabetes","volume":"55","author":"Proctor","year":"2006","journal-title":"Diabetes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1507\/endocrj.EJ19-0133","article-title":"Expression and Pathophysiological Significance of Carbohydrate Response Element Binding Protein (Chrebp) in the Renal Tubules of Diabetic Kidney","volume":"67","author":"Suzuki","year":"2020","journal-title":"Endocr. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"32317","DOI":"10.1074\/jbc.M500801200","article-title":"Diet-Induced Obesity in C57bl\/6j Mice Causes Increased Renal Lipid Accumulation and Glomerulosclerosis Via a Sterol Regulatory Element-Binding Protein-1c-Dependent Pathway","volume":"280","author":"Jiang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e135626","DOI":"10.1172\/jci.insight.135626","article-title":"Discordant Hepatic Fatty Acid Oxidation and Triglyceride Hydrolysis Leads to Liver Disease","volume":"6","author":"Selen","year":"2021","journal-title":"JCI Insight"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The Role and Regulation of the Peroxisome Proliferator Activated Receptor Alpha in Human Liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"Pparalpha Gene Expression Correlates with Severity and Histological Treatment Response in Patients with Non-Alcoholic Steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41419-019-1458-8","article-title":"Ppardelta Attenuates Hepatic Steatosis through Autophagy-Mediated Fatty Acid Oxidation","volume":"10","author":"Tong","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective Fatty Acid Oxidation in Renal Tubular Epithelial Cells Has a Key Role in Kidney Fibrosis Development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2017070802","article-title":"Impairment of Pparalpha and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis During Aging","volume":"29","author":"Chung","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e130317","DOI":"10.1172\/jci.insight.130317","article-title":"Increased Lipogenesis and Impaired Beta-Oxidation Predict Type 2 Diabetic Kidney Disease Progression in American Indians","volume":"4","author":"Afshinnia","year":"2019","journal-title":"JCI Insight"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/hep.31161","article-title":"The Patatin-Like Phospholipase Domain Containing Protein 7 Facilitates Vldl Secretion by Modulating Apoe Stability","volume":"72","author":"Wang","year":"2020","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional Very-Low-Density Lipoprotein Synthesis and Release Is a Key Factor in Nonalcoholic Steatohepatitis Pathogenesis","volume":"50","author":"Fujita","year":"2009","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1172\/JCI129769","article-title":"Nuclear Envelope-Localized Torsina-Lap1 Complex Regulates Hepatic Vldl Secretion and Steatosis","volume":"129","author":"Shin","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.7150\/thno.47037","article-title":"Dysfunction of Estrogen-Related Receptor Alpha-Dependent Hepatic Vldl Secretion Contributes to Sex Disparity in Nafld\/Nash Development","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2008.12.013","article-title":"Cideb, an Er- and Lipid Droplet-Associated Protein, Mediates Vldl Lipidation and Maturation by Interacting with Apolipoprotein B","volume":"9","author":"Ye","year":"2009","journal-title":"Cell Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.24066","article-title":"Hepatocyte Nuclear Factor-4 Alpha Regulates Liver Triglyceride Metabolism in Part through Secreted Phospholipase a(2) Gxiib","volume":"53","author":"Guan","year":"2011","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mce.2016.07.027","article-title":"Activation of Farnesoid X Receptor Promotes Triglycerides Lowering by Suppressing Phospholipase A2 G12b Expression","volume":"436","author":"Liu","year":"2016","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"p1","DOI":"10.1159\/000151272","article-title":"Very-Low-Density Lipoprotein-Induced Triglyceride Accumulation in Human Mesangial Cells Is Mainly Mediated by Lipoprotein Lipase","volume":"110","author":"Li","year":"2008","journal-title":"Nephron. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e1901141","DOI":"10.1002\/mnfr.201901141","article-title":"Chronic Stress Potentiates High Fructose-Induced Lipogenesis in Rat Liver and Kidney","volume":"64","author":"Milutinovic","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.molmed.2015.08.005","article-title":"Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease","volume":"21","author":"Musso","year":"2015","journal-title":"Trends Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: The Central Role of Nontriglyceride Fatty Acid Metabolites","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature09968","article-title":"Aberrant Lipid Metabolism Disrupts Calcium Homeostasis Causing Liver Endoplasmic Reticulum Stress in Obesity","volume":"473","author":"Fu","year":"2011","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/egh.11.6","article-title":"Apoptosis in Nonalcoholic Fatty Liver Disease: Diagnostic and Therapeutic Implications","volume":"5","author":"Alkhouri","year":"2011","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cld.2009.07.003","article-title":"Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis","volume":"13","author":"Syn","year":"2009","journal-title":"Clin. Liver Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11892-019-1263-x","article-title":"Crosstalk between Lipids and Mitochondria in Diabetic Kidney Disease","volume":"19","author":"Ducasa","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1111\/bph.15099","article-title":"Astaxanthin Attenuates Hepatic Damage and Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease by up-Regulating the Fgf21\/Pgc-1alpha Pathway","volume":"177","author":"Wu","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mito.2020.12.010","article-title":"Mitochondrial Dysfunction as a Mechanistic Biomarker in Patients with Non-Alcoholic Fatty Liver Disease (Nafld)","volume":"57","author":"Ajaz","year":"2021","journal-title":"Mitochondrion"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-Alcoholic Fatty Liver Disease (Nafld)\u2014Pathogenesis, Classification, and Effect on Drug Metabolizing Enzymes and Transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxidative Med. Cell Longev."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Nishi, H., Higashihara, T., and Inagi, R. (2019). Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction. Nutrients, 11.","DOI":"10.3390\/nu11071664"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","article-title":"Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function","volume":"12","author":"Welsh","year":"2010","journal-title":"Cell Metab."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Chen, J.H., Wu, C.H., and Chiang, C.K. (2021). Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168674"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-nutr-071811-150644","article-title":"Endoplasmic Reticulum Stress in Nonalcoholic Fatty Liver Disease","volume":"32","author":"Pagliassotti","year":"2012","journal-title":"Annu. Rev. Nutr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"63370","DOI":"10.18632\/oncotarget.18812","article-title":"Dysregulated Expression of Proteins Associated with Er Stress, Autophagy and Apoptosis in Tissues from Nonalcoholic Fatty Liver Disease","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic Reticulum Stress Signalling and the Pathogenesis of Non-Alcoholic Fatty Liver Disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e1879","DOI":"10.1038\/cddis.2015.248","article-title":"Er Stress Induces Nlrp3 Inflammasome Activation and Hepatocyte Death","volume":"6","author":"Lebeaupin","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"F821","DOI":"10.1152\/ajprenal.00196.2010","article-title":"Regulation of Podocyte Survival and Endoplasmic Reticulum Stress by Fatty Acids","volume":"299","author":"Sieber","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1152\/ajprenal.00223.2015","article-title":"Intrarenal Renin-Angiotensin System Mediates Fatty Acid-Induced Er Stress in the Kidney","volume":"310","author":"Li","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"F266","DOI":"10.1152\/ajprenal.00482.2011","article-title":"Er Stress Contributes to Renal Proximal Tubule Injury by Increasing Srebp-2-Mediated Lipid Accumulation and Apoptotic Cell Death","volume":"303","author":"Lhotak","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molmed.2011.07.010","article-title":"Endoplasmic Reticulum Stress, Obesity and Diabetes","volume":"18","author":"Cnop","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/nep.12748","article-title":"Endoplasmic Reticulum Stress Participates in Inflammation-Accelerated, Lipid-Mediated Injury of Human Glomerular Mesangial Cells","volume":"22","author":"Yang","year":"2017","journal-title":"Nephrology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.freeradbiomed.2010.03.021","article-title":"Lipotoxicity in Renal Proximal Tubular Cells: Relationship between Endoplasmic Reticulum Stress and Oxidative Stress Pathways","volume":"48","author":"Katsoulieris","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbrc.2010.10.012","article-title":"Oleate and Eicosapentaenoic Acid Attenuate Palmitate-Induced Inflammation and Apoptosis in Renal Proximal Tubular Cell","volume":"402","author":"Soumura","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Martinez-Garcia, C., Izquierdo-Lahuerta, A., Vivas, Y., Velasco, I., Yeo, T.K., Chen, S., and Medina-Gomez, G. (2015). Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142291"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"F1241","DOI":"10.1152\/ajprenal.00379.2019","article-title":"Lipid Mediators of Insulin Signaling in Diabetic Kidney Disease","volume":"317","author":"Mitrofanova","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ki.2015.305","article-title":"Molecular Mechanisms of Insulin Resistance in Chronic Kidney Disease","volume":"88","author":"Thomas","year":"2015","journal-title":"Kidney Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","article-title":"Pathophysiology of Diabetic Dyslipidemia","volume":"25","author":"Hirano","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","article-title":"Lipid Management in Patients with Chronic Kidney Disease","volume":"14","author":"Ferro","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1681\/ASN.2006091006","article-title":"Lipoprotein Metabolism and Lipid Management in Chronic Kidney Disease","volume":"18","author":"Kwan","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Lin, Y.C., Wang, J.C., Wu, M.S., Lin, Y.F., Chen, C.R., Chen, C.Y., Chen, K.C., and Peng, C.C. (2020). Nifedipine Exacerbates Lipogenesis in the Kidney Via Kim-1, Cd36, and Srebp Upregulation: Implications from an Animal Model for Human Study. Int. J. Mol. Sci, 21.","DOI":"10.3390\/ijms21124359"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11906-012-0250-2","article-title":"Lipid Nephrotoxicity: New Concept for an Old Disease","volume":"14","author":"Gyebi","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","article-title":"Plasma Lipids and Risk of Developing Renal Dysfunction: The Atherosclerosis Risk in Communities Study","volume":"58","author":"Muntner","year":"2000","journal-title":"Kidney Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of New-Onset Kidney Disease in a Community-Based Population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000321845","article-title":"Lipid Disorders and Their Relevance to Outcomes in Chronic Kidney Disease","volume":"31","author":"Vaziri","year":"2011","journal-title":"Blood Purif."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10157-013-0866-9","article-title":"Lipoprotein Metabolism and Ckd: Overview","volume":"18","author":"Barter","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1476-511X-13-100","article-title":"Nonalcoholic Steatohepatitis Is Associated with an Atherogenic Lipoprotein Subfraction Profile","volume":"13","author":"Corey","year":"2014","journal-title":"Lipids Health Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e12493","DOI":"10.1111\/jpi.12493","article-title":"Melatonin Improves Insulin Resistance and Hepatic Steatosis through Attenuation of Alpha-2-Hs-Glycoprotein","volume":"65","author":"Heo","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ki.2008.195","article-title":"Fat Redistribution and Adipocyte Transformation in Uninephrectomized Rats","volume":"74","author":"Zhao","year":"2008","journal-title":"Kidney Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"F558","DOI":"10.1152\/ajprenal.00137.2018","article-title":"Adiponectin Attenuates Kidney Injury and Fibrosis in Deoxycorticosterone Acetate-Salt and Angiotensin Ii-Induced Ckd Mice","volume":"315","author":"Tian","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fendo.2015.00168","article-title":"Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders","volume":"6","author":"Zhang","year":"2015","journal-title":"Front. Endocrinol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased Serum Fgf21 Levels in Patients with Nonalcoholic Fatty Liver Disease","volume":"40","author":"Yilmaz","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ghir.2007.06.003","article-title":"The Role of the Type I Insulin-Like Growth Factor Receptor (Igf-Ir) in Glomerular Integrity","volume":"18","author":"Bridgewater","year":"2008","journal-title":"Growth Horm. IGF Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000504172","article-title":"Complement C3 and Nonalcoholic Fatty Liver Disease in Chronic Kidney Disease Patients: A Pilot Study","volume":"45","author":"Pan","year":"2020","journal-title":"Kidney Blood Press. Res."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Akahane, T., Akahane, M., Namisaki, T., Kaji, K., Moriya, K., Kawaratani, H., Takaya, H., Sawada, Y., Shimozato, N., and Fujinaga, Y. (2020). Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061635"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","article-title":"Intestinal Microbiome and Nafld: Molecular Insights and Therapeutic Perspectives","volume":"55","author":"Hu","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"104617","DOI":"10.1016\/j.phrs.2019.104617","article-title":"The Gut-Liver-Kidney Axis: Novel Regulator of Fatty Liver Associated Chronic Kidney Disease","volume":"152","author":"Raj","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneph.2017.18","article-title":"Hypertension: Thrombin Amplification Loop in Hypertension","volume":"13","author":"Allison","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.molmet.2016.06.003","article-title":"Non-Alcoholic Fatty Liver and the Gut Microbiota","volume":"5","author":"Bashiardes","year":"2016","journal-title":"Mol. Metab."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000447276","article-title":"Extrahepatic Diseases and Nafld: The Triangular Relationship between Nafld, Type 2-Diabetes and Dysbiosis","volume":"34","author":"Scorletti","year":"2016","journal-title":"Dig. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tiv.2019.01.003","article-title":"Uremic Solutes Modulate Hepatic Bile Acid Handling and Induce Mitochondrial Toxicity","volume":"56","author":"Weigand","year":"2019","journal-title":"Toxicol. In Vitro"},{"key":"ref_108","unstructured":"(2021, August 25). Forxiga Approved in the Eu for the Treatment of Chronic Kidney Disease in Patients with and without Type-2 Diabetes. Available online: https:\/\/bit.ly\/3lXr8Bm."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.ajkd.2008.12.031","article-title":"Glucose Control by the Kidney: An Emerging Target in Diabetes","volume":"53","author":"Marsenic","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.ajkd.2018.03.022","article-title":"Sglt2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review","volume":"72","author":"Alicic","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/00325481.2019.1549459","article-title":"Efficacy and Renal Outcomes of Sglt2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease","volume":"131","author":"Kelly","year":"2019","journal-title":"Postgrad. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00125-019-4859-4","article-title":"Canagliflozin Reduces Inflammation and Fibrosis Biomarkers: A Potential Mechanism of Action for Beneficial Effects of Sglt2 Inhibitors in Diabetic Kidney Disease","volume":"62","author":"Heerspink","year":"2019","journal-title":"Diabetologia"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.3748\/wjg.v25.i28.3664","article-title":"Role of Sodium-Glucose Co-Transporter-2 Inhibitors in the Management of Nonalcoholic Fatty Liver Disease","volume":"25","author":"Kontana","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"107492","DOI":"10.1016\/j.intimp.2021.107492","article-title":"The Sglt2 Inhibitor Empagliflozin Negatively Regulates Il-17\/Il-23 Axis-Mediated Inflammatory Responses in T2dm with Nafld Via the Ampk\/Mtor\/Autophagy Pathway","volume":"94","author":"Meng","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bph.14859","article-title":"Delayed Intervention with a Novel Sglt2 Inhibitor Ngi001 Suppresses Diet-Induced Metabolic Dysfunction and Non-Alcoholic Fatty Liver Disease in Mice","volume":"177","author":"Chiang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/acs.jmedchem.7b01285","article-title":"Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (Ppar) Alpha\/Gamma\/Delta Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate","volume":"61","author":"Boubia","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-015-2576-y","article-title":"Resveratrol Prevents Renal Lipotoxicity in High-Fat Diet-Treated Mouse Model through Regulating Ppar-Alpha Pathway","volume":"411","author":"Zhou","year":"2016","journal-title":"Mol. Cell Biochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X Nuclear Receptor Ligand Obeticholic Acid for Non-Cirrhotic, Non-Alcoholic Steatohepatitis (Flint): A Multicentre, Randomised, Placebo-Controlled Trial","volume":"385","author":"Loomba","year":"2015","journal-title":"Lancet"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/dc15-1182","article-title":"Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities","volume":"39","author":"Musso","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","article-title":"Control of the Peroxisomal Beta-Oxidation Pathway by a Novel Family of Nuclear Hormone Receptors","volume":"68","author":"Dreyer","year":"1992","journal-title":"Cell"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic Steatohepatitis: The Role of Peroxisome Proliferator-Activated Receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_122","first-page":"BR532","article-title":"Agonists of Peroxisome-Proliferator Activated Receptor-Alpha (Clofibrate and Wy14643) Reduce Renal Ischemia\/Reperfusion Injury in the Rat","volume":"8","author":"Sivarajah","year":"2002","journal-title":"Med. Sci. Monit."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement with Rosiglitazone Therapy (Flirt) Trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41401-019-0319-4","article-title":"Asiatic Acid Prevents Renal Fibrosis in Uuo Rats Via Promoting the Production of 15d-Pgj2, an Endogenous Ligand of Ppar-Gamma","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/164_2019_228","article-title":"Pharmacologic Modulation of Bile Acid-Fxr-Fgf15\/Fgf19 Pathway for the Treatment of Nonalcoholic Steatohepatitis","volume":"256","author":"Schumacher","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41419-021-03620-z","article-title":"The Critical Role of Fxr Is Associated with the Regulation of Autophagy and Apoptosis in the Progression of Aki to Ckd","volume":"12","author":"Kim","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00592-020-01652-z","article-title":"Farnesoid X Receptor (Fxr) Agonist Ameliorates Systemic Insulin Resistance, Dysregulation of Lipid Metabolism, and Alterations of Various Organs in a Type 2 Diabetic Kidney Animal Model","volume":"58","author":"Han","year":"2021","journal-title":"Acta Diabetol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct Effects of Thyroid Hormones on Hepatic Lipid Metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1111\/bph.15427","article-title":"Activation of Thyroid Hormone Receptor-Beta Improved Disease Activity and Metabolism Independent of Body Weight in a Mouse Model of Non-Alcoholic Steatohepatitis and Fibrosis","volume":"178","author":"Kannt","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (Mgl-3196) for the Treatment of Non-Alcoholic Steatohepatitis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1038\/s41598-019-42905-4","article-title":"The Relationship between Thyroid Dysfunction and Nephrotic Syndrome: A Clinicopathological Study","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Hanai, S., Uchimura, K., Takahashi, K., Ishii, T., Mitsui, T., and Furuya, F. (2021). Hypoxia-Induced Thyroid Hormone Receptor Expression Regulates Cell-Cycle Progression in Renal Tubule Epithelial Cells. Endocr. J., EJ21-0245.","DOI":"10.1507\/endocrj.EJ21-0245"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence Variations in Pcsk9, Low Ldl, and Protection against Coronary Heart Disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.2174\/1381612824666181010123127","article-title":"The Role of Pcsk9 in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and the Effect of Pcsk9 Inhibitors","volume":"24","author":"Theocharidou","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"158792","DOI":"10.1016\/j.bbalip.2020.158792","article-title":"Hepatic and Circulating Levels of Pcsk9 in Morbidly Obese Patients: Relation with Severity of Liver Steatosis","volume":"1865","author":"Emma","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.numecd.2020.11.009","article-title":"Analysis of Steatosis Biomarkers and Inflammatory Profile after Adding on Pcsk9 Inhibitor Treatment in Familial Hypercholesterolemia Subjects with Nonalcoholic Fatty Liver Disease: A Single Lipid Center Real-World Experience","volume":"31","author":"Scicali","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cellsig.2018.12.001","article-title":"Novel Aspects of Pcsk9 and Lipoprotein Receptors in Renal Disease-Related Dyslipidemia","volume":"55","author":"Shrestha","year":"2019","journal-title":"Cell Signal."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"105228","DOI":"10.1016\/j.phrs.2020.105228","article-title":"Fatp2-Targeted Therapies\u2014A Role Beyond Fatty Liver Disease","volume":"161","author":"Qiu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"601290","DOI":"10.3389\/fendo.2020.601290","article-title":"Fgf21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases","volume":"11","author":"Tillman","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"Mir-122 Regulation of Lipid Metabolism Revealed by in Vivo Antisense Targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1097\/HJH.0000000000001770","article-title":"Hypertension Exaggerates Renovascular Resistance Via Mir-122-Associated Stress Response in Aging","volume":"36","author":"Weber","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"Mir-33a\/B Contribute to the Regulation of Fatty Acid Metabolism and Insulin Signaling","volume":"108","author":"Davalos","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"121ra118","DOI":"10.1126\/scitranslmed.3003205","article-title":"Microrna-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways","volume":"4","author":"Chau","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of Nafld Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4254\/wjh.v12.i12.1258","article-title":"Effects of Proprotein Convertase Subtilisin\/Kexin Type-9 Inhibitors on Fatty Liver","volume":"12","author":"Shafiq","year":"2020","journal-title":"World J. Hepatol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","article-title":"Total Fecal Microbiota Transplantation Alleviates High-Fat Diet-Induced Steatohepatitis in Mice Via Beneficial Regulation of Gut Microbiota","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00394-018-1785-z","article-title":"An Open-Label, Randomized, Placebo-Controlled Study on the Effectiveness of a Novel Probiotics Administration Protocol (Probiotickd) in Patients with Mild Renal Insufficiency (Stage 3a of Ckd)","volume":"58","author":"Simeoni","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The Links between the Gut Microbiome and Non-Alcoholic Fatty Liver Disease (Nafld)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jnutbio.2012.01.014","article-title":"Lactobacillus Casei Shirota Protects from Fructose-Induced Liver Steatosis: A Mouse Model","volume":"24","author":"Wagnerberger","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Ma, J., Zhou, Q., and Li, H. (2017). Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients, 9.","DOI":"10.20944\/preprints201709.0040.v2"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s11255-019-02291-2","article-title":"The Gut Microbiota and Its Relationship with Chronic Kidney Disease","volume":"51","author":"Plata","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MPG.0000000000001422","article-title":"Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents","volume":"64","author":"Famouri","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/07315724.2015.1031355","article-title":"Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial","volume":"35","author":"Sepideh","year":"2016","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s10157-019-01727-4","article-title":"Effects of Lactulose on Renal Function and Gut Microbiota in Adenine-Induced Chronic Kidney Disease Rats","volume":"23","author":"Sueyoshi","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1096\/fj.14-259515","article-title":"Commensal Microbiota Is Hepatoprotective and Prevents Liver Fibrosis in Mice","volume":"29","author":"Mazagova","year":"2015","journal-title":"FASEB J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3904\/kjim.2020.411","article-title":"The Clinical Impact of Gut Microbiota in Chronic Kidney Disease","volume":"35","author":"Kim","year":"2020","journal-title":"Korean J. Intern. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"F1211","DOI":"10.1152\/ajprenal.00298.2018","article-title":"Chronic Kidney Disease and the Gut Microbiome","volume":"316","author":"Hobby","year":"2019","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/hep.26470","article-title":"Adipose Tissue-Derived Stem Cells as a Regenerative Therapy for a Mouse Steatohepatitis-Induced Cirrhosis Model","volume":"58","author":"Seki","year":"2013","journal-title":"Hepatology"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Farouk, S., Sabet, S., Abu Zahra, F.A., and El-Ghor, A.A. (2018). Bone Marrow Derived-Mesenchymal Stem Cells Downregulate Il17a Dependent Il6\/Stat3 Signaling Pathway in Ccl4-Induced Rat Liver Fibrosis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206130"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.intimp.2016.11.012","article-title":"Compact Bone-Derived Mesenchymal Stem Cells Attenuate Nonalcoholic Steatohepatitis in a Mouse Model by Modulation of Cd4 Cells Differentiation","volume":"42","author":"Wang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory Mechanisms of Mesenchymal Stem and Stromal Cells in Inflammatory Diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"34842","DOI":"10.1038\/srep34842","article-title":"Mesenchymal Stem Cell Therapy Ameliorates Diabetic Nephropathy Via the Paracrine Effect of Renal Trophic Factors Including Exosomes","volume":"6","author":"Nagaishi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.kint.2016.12.023","article-title":"Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Kidney Inflammation","volume":"92","author":"Eirin","year":"2017","journal-title":"Kidney Int."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/stem.1263","article-title":"Mesenchymal Stem Cells and Endothelial Progenitor Cells Decrease Renal Injury in Experimental Swine Renal Artery Stenosis through Different Mechanisms","volume":"31","author":"Zhu","year":"2013","journal-title":"Stem Cells"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/stem.214","article-title":"Mesenchymal Stem Cells Attenuate Renal Fibrosis through Immune Modulation and Remodeling Properties in a Rat Remnant Kidney Model","volume":"27","author":"Semedo","year":"2009","journal-title":"Stem Cells"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s42255-020-0222-9","article-title":"The Small Intestine Shields the Liver from Fructose-Induced Steatosis","volume":"2","author":"Jang","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Do, M.H., Lee, E., Oh, M.J., Kim, Y., and Park, H.Y. (2018). High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in Mice without Body Weight Change. Nutrients, 10.","DOI":"10.3390\/nu10060761"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"G542","DOI":"10.1152\/ajpgi.00286.2019","article-title":"Vitamin D Signaling Maintains Intestinal Innate Immunity and Gut Microbiota: Potential Intervention for Metabolic Syndrome and Nafld","volume":"318","author":"Zeng","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1405\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:09:51Z","timestamp":1760166591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":169,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["biomedicines9101405"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9101405","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]}}}